Cost-Effectiveness Analysis Dashboards

1. Prophylactic Weekly Efanesoctocog Alfa Versus Standard-Care Factor VIII in People Living With Severe Hemophilia A: A Cost-Effectiveness Analysis

Link to dashboard: https://manrajsra.shinyapps.io/EFA_Shiny_April_2025/
Link to paper: https://doi.org/10.7326/ANNALS-24-02749

2. Emicizumab for Preventing Intracranial Hemorrhage in Infants With Severe Hemophilia A: A Cost-Effectiveness Analysis

Link to dashboard: https://manrajsra.shinyapps.io/EMI_CEA_Dashboard/
Link to paper: https://doi.org/10.1182/bloodadvances.2025016822